Tarrina Resources Limited (ASX: TR8) has formally recommenced trading on the ASX following the successful completion of a $5 million capital raising, enabling the Company to immediately progress exploration across its NSW and South Australian assets. The Company’s flagship asset—the Christmas Gift Gold Project, located 15 km east of Cootamundra within the southern Lachlan Fold Belt (Figure 1)

FMR Resources Limited (ASX: FMR) has provided an update from the Llahuin Project Joint Venture in Chile, where it partners with Southern Hemisphere Mining Limited (ASX: SUH). Drilling at Target A – Southern Porphyry has now advanced to 1,198.9 metres downhole, intersecting zones of copper-bearing veining and strong potassic–biotite alteration above the main magnetotelluric (MT) anomaly.

Mount Ridley Mines Limited (ASX: MRD) has announced a significant expansion of its tenure at the Mount Ridley Gallium and Rare Earth Project, located north of Esperance, Western Australia (Figure 1). The new Exploration Licences now consolidate the entire Grass Patch Complex — a distinctive geological domain marked by gravity and magnetic highs, interpreted to be associated with mafic intrusions, and recognised as a primary source of gallium and heavy rare earth enrichment.

OD6 Metals Limited (ASX: OD6) has announced the publication of a peer-reviewed scientific paper detailing three years of advanced geological and geochemical work at the Company’s flagship Splinter Rock Rare Earth Project in Western Australia (Figure 1). The research—undertaken by CSIRO, Murdoch University, Monash University, and OD6—provides a technical, science-backed understanding of how rare earth elements (REE) occur, concentrate, and can be extracted from this large clay

Echo IQ Limited (ASX: EIQ) is pushing its cardiology decision-support platform into the heart failure space, with its EchoSolv HF algorithm now validated through the Mayo Clinic Platform’s independent “Validate” program in the United States. The Company, based in Sydney with operations anchored out of Western Australia, has completed what it describes as the final clinical requirement ahead of a planned FDA 510(k) submission for EchoSolv HF – a heart failure decision-support